Hyperlactatemia and hyperammonemia as secondary effects of valproic acid poisoning

被引：12

作者：

Thabet, H ^{[1
]}

Brahmi, N ^{[1
]}

Amamou, M ^{[1
]}

Ben Salah, N ^{[1
]}

Hédhili, A ^{[1
]}

机构：

[1] Ctr Assistance Med Urgente Montfleury, Instens Care Unit, Tunis, Tunisia

来源：

AMERICAN JOURNAL OF EMERGENCY MEDICINE | 2000年 / 18卷 / 04期

关键词：

D O I：

10.1053/ajem.2000.3981

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：508 / 508

页数：1

共 8 条

[1]

BerthelotMoritz F, 1997, INTENS CARE MED, V23, P599

[2] Fulminant progression of demyelinating disease after valproate-induced encephalopathy [J].

Blindauer, KA ;

Harrington, G ;

Morris, GL ;

Ho, KC .

NEUROLOGY, 1998, 51 (01) :292-295

[3] Valproic acid hepatic fatalities .3. US experience since 1986 [J].

Bryant, AE ;

Dreifuss, FE .

NEUROLOGY, 1996, 46 (02) :465-469

[4]

Dumoulin A, 1997, PRESSE MED, V26, P555

[5] ACUTE VALPROIC ACID INTOXICATION - ENHANCED DRUG CLEARANCE WITH ORAL-ACTIVATED CHARCOAL [J].

FARRAR, HC ;

HEROLD, DA ;

REED, MD .

CRITICAL CARE MEDICINE, 1993, 21 (02) :299-301

[6] VALPROIC ACID AND SECONDARY HYPERAMMONEMIA [J].

RAWAT, S ;

BORKOWSKI, WJ ;

SWICK, HM .

NEUROLOGY, 1981, 31 (09) :1173-1174

[7]

SCHNABEL R, 1984, LANCET, V1, P221

[8]

WENLING L, 1998, VET HUM TOXICOL, V40, P346

← 1 →